Lilly Walks Away As Roche Dominates EU’s COVID-19 Antibody Market

Sales Dwindled After Delta Fears

 
• By Andrew McConaghie
  
Eli Lilly logo sign atop Lilly Biotechnology Center
Lilly's revenues have exceed expectations this year thanks to US sales of its COVID-19 antibody therapy - but the picture is very different in Europe. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip